Oct 2026
Individualized Antiplatelet Therapy After Percutaneous Coronary Intervention for Acute Coronary Syndrome: Current SAPT Strategies and the Potential Role of Indobufen.
Current evidence suggests that indobufen-based DAPT may provide comparable ischemic protection with fewer bleeding or gastrointestinal adverse events in selected PCI patients, particularly those with aspirin intolerance, gastrointestinal vulnerability, or high bleeding risk.
Jia-Hui Chai, Xue-Bo Li, Qian Liu et al.
· Cardiology in Review · 0 citations